AAAAAA

   
Results: 1-9 |
Results: 9
EFFECTS OF NITRIC-OXIDE MANIPULATION ON THE DISPOSITION OF PLATINUM IN AN EXPERIMENTAL GLIOMA MODEL
Authors: MALCOLM GP JODRELL DI MACLELLAN A SWAROOP GR KELLY PAT WHITTLE IR
Citation: Gp. Malcolm et al., EFFECTS OF NITRIC-OXIDE MANIPULATION ON THE DISPOSITION OF PLATINUM IN AN EXPERIMENTAL GLIOMA MODEL, NeuroReport, 9(2), 1998, pp. 181-185
PHASE-I AND PHARMACOKINETIC STUDY OF ANTAGONIST-G - A BROAD-SPECTRUM NEUROPEPTIDE GROWTH-FACTOR ANTAGONIST USING A RAPID DOSE-ESCALATION STRATEGY
Authors: CLIVE S JODRELL D MACLELLAN A YOUNG A MILLER M CUMMINGS J SMYTH JF
Citation: S. Clive et al., PHASE-I AND PHARMACOKINETIC STUDY OF ANTAGONIST-G - A BROAD-SPECTRUM NEUROPEPTIDE GROWTH-FACTOR ANTAGONIST USING A RAPID DOSE-ESCALATION STRATEGY, Annals of oncology, 9, 1998, pp. 469-469
DOSE LIMITING NEUROTOXICITY IN A PHASE-I STUDY OF PENCLOMEDINE (NSC-388720, CRC-88-04), A SYNTHETIC ALPHA-PICOLINE DERIVATIVE, ADMINISTEREDINTRAVENOUSLY
Authors: JODRELL DI BOWMAN A STEWART M DUNLOP N FRENCH R MACLELLAN A CUMMINGS J SMYTH JF
Citation: Di. Jodrell et al., DOSE LIMITING NEUROTOXICITY IN A PHASE-I STUDY OF PENCLOMEDINE (NSC-388720, CRC-88-04), A SYNTHETIC ALPHA-PICOLINE DERIVATIVE, ADMINISTEREDINTRAVENOUSLY, British Journal of Cancer, 77(5), 1998, pp. 808-811
IS THERE A FUTURE FOR MAHOGANY - PAPERS PRESENTED AT A MEETING ON THEFUTURE FOR THE GENUS SWIETENIA IN ITS NATIVE FORESTS, HELD AT THE LINNAEAN-SOCIETY, 8 SEPTEMBER 1994 - FOREWORD
Authors: MACLELLAN A
Citation: A. Maclellan, IS THERE A FUTURE FOR MAHOGANY - PAPERS PRESENTED AT A MEETING ON THEFUTURE FOR THE GENUS SWIETENIA IN ITS NATIVE FORESTS, HELD AT THE LINNAEAN-SOCIETY, 8 SEPTEMBER 1994 - FOREWORD, Biological Journal of the Linnean Society, 122(1), 1996, pp. 1-2
CHARACTERIZATION OF THE DEAMIDASE ENZYME RESPONSIBLE FOR THE METABOLISM OF THE ANTICANCER PEPTIDE - H-ARG-D-TRP-N(ME)PHE-D-TRP-LEU-MET-NH2
Authors: JONES DA CUMMINGS J LANGDON SP MACLELLAN A SMYTH JF
Citation: Da. Jones et al., CHARACTERIZATION OF THE DEAMIDASE ENZYME RESPONSIBLE FOR THE METABOLISM OF THE ANTICANCER PEPTIDE - H-ARG-D-TRP-N(ME)PHE-D-TRP-LEU-MET-NH2, Biochemical pharmacology, 50(5), 1995, pp. 585-590
DETERMINATION OF 2 NEUROPEPTIDE GROWTH-FACTOR ANTAGONISTS, [D-ARG(1),D-PHE(5),D-TRP(7,9),LEU(11)]-SUBSTANCE P AND [ARG(6),D-TRP(7,9),N-MEPHE(8)]-SUBSTANCE P(6-11), BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION (VOL 653, PG 195 1994)
Authors: CUMMINGS J MACLELLAN A LANGDON SP ROZENGURT E SMYTH JF
Citation: J. Cummings et al., DETERMINATION OF 2 NEUROPEPTIDE GROWTH-FACTOR ANTAGONISTS, [D-ARG(1),D-PHE(5),D-TRP(7,9),LEU(11)]-SUBSTANCE P AND [ARG(6),D-TRP(7,9),N-MEPHE(8)]-SUBSTANCE P(6-11), BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION (VOL 653, PG 195 1994), Journal of chromatography B. Biomedical applications, 655(2), 1994, pp. 325-325
DETERMINATION OF 2 NEUROPEPTIDE GROWTH-FACTOR ANTAGONISTS, [D-ARG(1),D-PHE(5),D-TRP(7,9),LEU(11)]-SUBSTANCE-P AND [ARG(6),D-TRP(7,9),N-MEPHE(8)]-SUBSTANCE-P(6-11), BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION
Authors: CUMMINGS J MACLELLAN A LANGDON SP ROZENGURT E SMYTH JF
Citation: J. Cummings et al., DETERMINATION OF 2 NEUROPEPTIDE GROWTH-FACTOR ANTAGONISTS, [D-ARG(1),D-PHE(5),D-TRP(7,9),LEU(11)]-SUBSTANCE-P AND [ARG(6),D-TRP(7,9),N-MEPHE(8)]-SUBSTANCE-P(6-11), BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION, Journal of chromatography B. Biomedical applications, 653(2), 1994, pp. 195-203
STABILITY AND IN-VITRO METABOLISM OF THE MITOGENIC NEUROPEPTIDE ANTAGONISTS [D-ARG(1),D-PHE(5),D-TRP(7,9),LEU(11)]-SUBSTANCE-P AND [ARG(6),D-TRP(7,9),MEPHE(8)]-SUBSTANCE-P-(6-11) CHARACTERIZED BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
Authors: CUMMINGS J MACLELLAN A LANGDON SP SMYTH JF
Citation: J. Cummings et al., STABILITY AND IN-VITRO METABOLISM OF THE MITOGENIC NEUROPEPTIDE ANTAGONISTS [D-ARG(1),D-PHE(5),D-TRP(7,9),LEU(11)]-SUBSTANCE-P AND [ARG(6),D-TRP(7,9),MEPHE(8)]-SUBSTANCE-P-(6-11) CHARACTERIZED BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of pharmaceutical and biomedical analysis, 12(6), 1994, pp. 811-819
THE COMPARATIVE DISPOSITION OF THE PYROLLOQUINONE GR63178A AND ITS 9-HYDROXY METABOLITE GR54374X IN SENSITIVE AND RESISTANT MOUSE COLON ADENOCARCINOMA
Authors: FRENCH RC CUMMINGS J MACLELLAN A MACPHERSON JS RITCHIE AA SMYTH JF
Citation: Rc. French et al., THE COMPARATIVE DISPOSITION OF THE PYROLLOQUINONE GR63178A AND ITS 9-HYDROXY METABOLITE GR54374X IN SENSITIVE AND RESISTANT MOUSE COLON ADENOCARCINOMA, Cancer chemotherapy and pharmacology, 32(2), 1993, pp. 156-161
Risultati: 1-9 |